Business Description
CF PharmTech Inc
ISIN : CNE1000074R9
Share Class Description:
HKSE:02652: Ordinary Shares- Class HTotal Employee Number:
540Compare
Compare
Traded in other countries / regions
02652.Hong Kong Index Membership
Hong Kong Stock Connect IPO Date
2025-10-08Description
CF PharmTech Inc is engaged in inhalation drug delivery technology. It is dedicated to building multidisciplinary bridges between complex formulations and unmet clinical needs. The Company is a specialist in the development of complex inhalation formulations with high barriers to entry, and a platform-based pharmaceutical company with integrated capabilities spanning device engineering, precision drug delivery, international regulatory filing, and commercialization. Leveraging its self-developed, globally integrated end-to-end capabilities, from exhalation-powered nasal spray delivery systems and liposomal inhalation technology to small interfering RNA (siRNA) nucleic acid delivery platforms. Its therapeutic areas encompass respiratory diseases and nasal diseases.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 4.49 | |||||
Equity-to-Asset | 0.83 | |||||
Debt-to-Equity | 0.1 | |||||
Debt-to-EBITDA | 2.53 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | 11.82 | |||||
Beneish M-Score | 3.51 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -0.7 | |||||
3-Year FCF Growth Rate | -40.1 | |||||
3-Year Book Growth Rate | 19 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 48.55 | |||||
9-Day RSI | 50.69 | |||||
14-Day RSI | 49.55 | |||||
3-1 Month Momentum % | -20.16 | |||||
6-1 Month Momentum % | -50.82 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 4.59 | |||||
Quick Ratio | 4.4 | |||||
Cash Ratio | 3.37 | |||||
Days Inventory | 143.6 | |||||
Days Sales Outstanding | 65.33 | |||||
Days Payable | 72.02 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 75.82 | |||||
Operating Margin % | -1.59 | |||||
Net Margin % | 0.57 | |||||
EBITDA Margin % | 13.33 | |||||
FCF Margin % | -60.44 | |||||
OCF Margin % | -25.5 | |||||
ROE % | 0.21 | |||||
ROA % | 0.17 | |||||
ROC (Joel Greenblatt) % | -1.85 | |||||
ROCE % | -0.85 | |||||
Years of Profitability over Past 10-Year | 3 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 2478.57 | |||||
PE Ratio without NRI | 1445.83 | |||||
PS Ratio | 13.71 | |||||
PB Ratio | 4.4 | |||||
Price-to-Tangible-Book | 4.93 | |||||
EV-to-EBIT | -481.54 | |||||
EV-to-EBITDA | 90.78 | |||||
EV-to-Revenue | 12.1 | |||||
EV-to-FCF | -20.02 | |||||
Price-to-Graham-Number | 17.7 | |||||
| Price-to-Net-Current-Asset-Value | 11.12 | |||||
| Price-to-Net-Cash | 18.66 | |||||
Earnings Yield (Greenblatt) % | -0.21 | |||||
FCF Yield % | -4.53 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
CF PharmTech Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 477.817 | ||
| EPS (TTM) (HK$) | 0.007 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 49.55 | ||
| 14-Day ATR (HK$) | 1.724265 | ||
| 20-Day SMA (HK$) | 16.5985 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (HK$) | 14.82 - 48.8 | ||
| Shares Outstanding (Mil) | 367.19 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
CF PharmTech Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
CF PharmTech Inc Stock Events
| Event | Date | Price (HK$) | ||
|---|---|---|---|---|
| No Event Data | ||||
CF PharmTech Inc Frequently Asked Questions
What is CF PharmTech Inc(HKSE:02652)'s stock price today?
The current price of HKSE:02652 is HK$17.35. The 52 week high of HKSE:02652 is HK$48.80 and 52 week low is HK$14.82.
When is next earnings date of CF PharmTech Inc(HKSE:02652)?
The next earnings date of CF PharmTech Inc(HKSE:02652) is .
Does CF PharmTech Inc(HKSE:02652) pay dividends? If so, how much?
CF PharmTech Inc(HKSE:02652) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on CF PharmTech Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers